Recursos
Key Findings: Bacterial Endotoxins Testing Using Recombinant Reagents and Innovative Microfluidic Technology
We collaborated with Eli Lilly to present research on recombinant reagents and microfluidic technology for Bacterial Endotoxins Testing (BET)at the Parenteral Drug Association (PDA) Pharmaceutical Microbiology Conference.
Our findings, based on real-world sample data, demonstrate the accuracy and reliability of recombinant agents on modern microbiological detection platforms. Jay Holden and Hayden Skalski present research at PDA Microbiology Conference